Mainz Biomed N.V. UNDERWRITING AGREEMENTUnderwriting Agreement • January 28th, 2022 • Mainz Biomed N.V. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 28th, 2022 Company Industry JurisdictionThis underwriting agreement (this “Agreement”) constitutes the agreement between Mainz Biomed N.V., a Dutch public company with limited liability (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereafter defined) as being subsidiaries or affiliates of the Company, the “Company”) on the one hand, and Boustead Securities, LLC (the “Underwriter”), on the other hand, pursuant to which the Underwriter shall serve as the underwriter for the Company in connection with the proposed offering (the “Offering”) by the Company of their Securities (as defined below) on a “Firm Commitment” basis.